Serendipitous discovery of short peptides from natural products as tyrosinase inhibitors

Journal of Chemical Information and Modeling

Volumn 54, Issue 11, 2014, Pages 3099-3111

  Hsiao, Nai Wan ^a   Tseng, Tien Sheng ^b   Lee, Yu Ching ^c   Chen, Wang Chuan ^d,e   Lin, Hui Hsiung ^b   Chen, Yun Ru ^a,f   Wang, Yeng Tseng ^g   Hsu, Hung Ju ^b   Tsai, Keng Chang ^b  

^a NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

^e E DA HOSPITAL   (Taiwan)

^f NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; HEAVY IONS; NEURODEGENERATIVE DISEASES; PEPTIDES; PHARMACODYNAMICS;

ADVERSE SIDE EFFECTS; CHEMICAL EQUATIONS; LONG TERM STABILITY; MUSHROOM TYROSINASE; PHARMACOPHORE MODELING; SERENDIPITOUS DISCOVERY; TYROSINASE INHIBITION; TYROSINASE INHIBITORS;

PLANTS (BOTANY);

BIOLOGICAL PRODUCT; ENZYME INHIBITOR; LIGAND; MONOPHENOL MONOOXYGENASE; OLIGOPEPTIDE;

ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DEVELOPMENT; METABOLISM; MOLECULAR DOCKING; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

BIOLOGICAL PRODUCTS; DRUG DISCOVERY; ENZYME INHIBITORS; LIGANDS; MOLECULAR DOCKING SIMULATION; MONOPHENOL MONOOXYGENASE; OLIGOPEPTIDES; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT;

EID: 84912553673     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci500370x     Document Type: Article

References (54)

1. Costin, G. E.; Hearing, V. J. Human skin pigmentation: Melanocytes modulate skin color in response to stress. FASEB J. 2007, 21, 976-994.
2. Alexis, A., Barbosa, V. H., Eds. Skin of Color: A Practical Guide to Dermatologic Diagnosis and Treatment ; Springer: Berlin, Heidelberg, 2013.
3. Piamphongsant, T. Treatment of melasma: A review with personal experience. Int. J. Dermatol. 1998, 37, 897-903.
4. Cavalieri, E. L.; Li, K. M.; Balu, N.; Saeed, M.; Devanesan, P.; Higginbotham, S.; Zhao, J.; Gross, M. L.; Rogan, E. G. Catechol orthoquinones: The electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002, 23, 1071-1077.
5. Kim, Y. J.; Uyama, H. Tyrosinase inhibitors from natural and synthetic sources: Structure, inhibition mechanism and perspective for the future. Cell. Mol. Life Sci. 2005, 62, 1707-1723.
6. Eisenhofer, G.; Tian, H.; Holmes, C.; Matsunaga, J.; Roffler-Tarlov, S.; Hearing, V. J. Tyrosinase: A developmentally specific major determinant of peripheral dopamine. FASEB J. 2003, 17, 1248-1255.
7. Chang, T. S. An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 2009, 10, 2440-2475.
8. Slominski, A.; Tobin, D. J.; Shibahara, S.; Wortsman, J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 2004, 84, 1155-1228.
9. Pan, T.; Li, X.; Jankovic, J. The association between Parkinson's disease and melanoma. Int. J. Cancer 2011, 128, 2251-2260.
10. Asanuma, M.; Miyazaki, I.; Ogawa, N. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res. 2003, 5, 165-176.
11. Seo, S. Y.; Sharma, V. K.; Sharma, N. Mushroom tyrosinase: Recent prospects. J. Agric. Food Chem. 2003, 51, 2837-2853.
12. Elsner, P.; Maibach, H. I. Cosmeceuticals: Drugs vs. Cosmetics; Cosmetic Science and Technology Series, Vol. 23 ; Marcel Dekker: New York, 2000.
13. Maeda, K.; Fukuda, M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J. Pharmacol. Exp. Ther. 1996, 276, 765-769.
14. Schurink, M.; van Berkel, W. J.; Wichers, H. J.; Boeriu, C. G. Novel peptides with tyrosinase inhibitory activity. Peptides 2007, 28, 485-495.
15. Germanas, J. P.; Wang, S.; Miner, A.; Hao, W.; Ready, J. M. Discovery of small-molecule inhibitors of tyrosinase. Bioorg. Med. Chem. Lett. 2007, 17, 6871-6875.
16. Smith, M. T.; Yager, J. W.; Steinmetz, K. L.; Eastmond, D. A. Peroxidase-dependent metabolism of benzene' s phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 1989, 82, 23-29.
17. Rossi, L.; Moore, G. A.; Orrenius, S.; O' Brien, P. J. Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 1986, 251, 25-35.
18. DeCaprio, A. P. The toxicology of hydroquinone - Relevance to occupational and environmental exposure. Crit. Rev. Toxicol. 1999, 29, 283-330.
19. Fuyuno, I. Spotlight turns on cosmetics for Asian skin. Nature 2004, 432, 938.
20. Girelli, A. M.; Mattei, E.; Messina, A.; Tarola, A. M. Inhibition of polyphenol oxidases activity by various dipeptides. J. Agric. Food Chem. 2004, 52, 2741-2745.
21. Abu Ubeid, A.; Zhao, L.; Wang, Y.; Hantash, B. M. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase. J. Invest. Dermatol. 2009, 129, 2242-2249.
22. Kim, H.; Choi, J.; Cho, J. K.; Kim, S. Y.; Lee, Y. S. Solid-phase synthesis of kojic acid -tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity. Bioorg. Med. Chem. Lett. 2004, 14, 2843-2846.
23. Morita, H.; K, T.; Kobata, H.; Gonda, A.; Takeya, K.; Itokawa, H. Pseudostellarins D -F, new tyrosinase inhibitory cyclic peptides from Pseudostellaria heterophylla . Tetrahedron 1994, 9975-9982.
24. Shimizu, K.; Kondo, R.; Sakai, K. Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: Structure - activity investigations. Planta Med. 2000, 66, 11-15.
25. Zheng, Z. P.; Cheng, K. W.; To, J. T.; Li, H.; Wang, M. Isolation of tyrosinase inhibitors from Artocarpus heterophyllus and use of its extract as antibrowning agent. Mol. Nutr. Food Res. 2008, 52, 1530-1538.
26. Tajima, R.; Oozeki, H.; Muraoka, S.; Tanaka, S.; Motegi, Y.; Nihei, H.; Yamada, Y.; Masuoka, N.; Nihei, K. Synthesis and evaluation of bibenzyl glycosides as potent tyrosinase inhibitors. Eur. J. Med. Chem. 2011, 46, 1374-1381.
27. Bao, K.; Dai, Y.; Zhu, Z. B.; Tu, F. J.; Zhang, W. G.; Yao, X. S. Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors. Bioorg. Med. Chem. 2010, 18, 6708-6714.
28. Yi, W.; Cao, R.; Peng, W.; Wen, H.; Yan, Q.; Zhou, B.; Ma, L.; Song, H. Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors. Eur. J. Med. Chem. 2010, 45, 639-646.
29. Casanola-Martin, G. M.; Marrero-Ponce, Y.; Tareq Hassan Khan, M.; Torrens, F.; Perez-Gimenez, F.; Rescigno, A. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors. J. Biomol. Screen. 2008, 13, 1014-1024.
30. Ryu, Y. B.; Westwood, I. M.; Kang, N. S.; Kim, H. Y.; Kim, J. H.; Moon, Y. H.; Park, K. H. Kurarinol, tyrosinase inhibitor isolated from the root of Sophora flavescens. Phytomedicine 2008, 15, 612-618.
31. Marrero-Ponce, Y.; Khan, M. T.; Casanola-Martin, G. M.; Ather, A.; Sultankhodzhaev, M. N.; Garcia-Domenech, R.; Torrens, F.; Rotondo, R. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: Aiding decision-making in "in silico" selection of new lead tyrosinase inhibitors. J. Comput. Aided Mol. Des. 2007, 21, 167-188.
32. Ahmad, V. U.; Ullah, F.; Hussain, J.; Farooq, U.; Zubair, M.; Khan, M. T.; Choudhary, M. I. Tyrosinase inhibitors from Rhododendron collettianum and their structure-activity relationship (SAR) studies. Chem. Pharm. Bull. (Tokyo) 2004, 52, 1458-1461.
33. Zheng, Z. P.; Zhu, Q.; Fan, C. L.; Tan, H. Y.; Wang, M. Phenolic tyrosinase inhibitors from the stems of Cudrania cochinchinensis. Food Funct. 2011, 2, 259-264.
34. Kim, J. M.; Ko, R. K.; Jung, D. S.; Kim, S. S.; Lee, N. H. Tyrosinase inhibitory constituents from the stems of Maackia fauriei. Phytother. Res. 2010, 24, 70-75.
35. Yi, W.; Cao, R.; Wen, H.; Yan, Q.; Zhou, B.; Ma, L.; Song, H. Discovery of 4-functionalized phenyl-O-beta-D-glycosides as a new class of mushroom tyrosinase inhibitors. Bioorg. Med. Chem. Lett. 2009, 19, 6157-6160.
36. Momtaz, S.; Mapunya, B. M.; Houghton, P. J.; Edgerly, C.; Hussein, A.; Naidoo, S.; Lall, N. Tyrosinase inhibition by extracts and constituents of Sideroxylon inerme L. stem bark, used in South Africa for skin lightening. J. Ethnopharmacol. 2008, 119, 507-512.
37. Yoon, N. Y.; Eom, T. K.; Kim, M. M.; Kim, S. K. Inhibitory effect of phlorotannins isolated from Ecklonia cava on mushroom tyrosinase activity and melanin formation in mouse B16F10 melanoma cells. J. Agric. Food Chem. 2009, 57, 4124-4129.
38. Morimura, K.; Yamazaki, C.; Hattori, Y.; Makabe, H.; Kamo, T.; Hirota, M. A tyrosinase inhibitor, Daedalin A, from mycelial culture of Daedalea dickinsii. Biosci., Biotechnol., Biochem. 2007, 71, 2837-2840.
39. Yi, W.; Cao, R.; Wen, H.; Yan, Q.; Zhou, B.; Wan, Y.; Ma, L.; Song, H. Synthesis and biological evaluation of helicid analogues as mushroom tyrosinase inhibitors. Bioorg. Med. Chem. Lett. 2008, 18, 6490-6493.
40. Matos, M. J.; Santana, L.; Uriarte, E.; Delogu, G.; Corda, M.; Fadda, M. B.; Era, B.; Fais, A. New halogenated phenylcoumarins as tyrosinase inhibitors. Bioorg. Med. Chem. Lett. 2011, 21, 3342-3345.
41. John, S.; Thangapandian, S.; Sakkiah, S.; Lee, K. W. Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies. BMC Bioinf. 2011, 12 (Suppl. 1), S28.
42. Sarma, R.; Sinha, S.; Ravikumar, M.; Kishore Kumar, M.; Mahmood, S. K. Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors. Eur. J. Med. Chem. 2008, 43, 2870-2876.
43. Tukamoto, T. T.; Taniguchi, T. Comparison of inhibitory effect of various chemical agents on tyrosinase activity by manometric method. J. Invest. Dermatol. 1958, 30, 305-310.
44. Jergil, B.; Lindbladh, C.; Rorsman, H.; Rosengren, E. Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine. Acta Derm. Venereol. 1984, 64, 155-157.
45. Ghani, U.; Ullah, N. New potent inhibitors of tyrosinase: Novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site. Bioorg. Med. Chem. 2010, 18, 4042-4048.
46. Schurink, M. Peptides as inhibitors of lipoxygenase and tyrosinase. Thesis, Wageningen University, Wageningen, The Netherlands, 2007.
47. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977, 23, 327-341.
48. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N· log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993, 98, 10089-10092.
49. Laskowski, R. A.; Swindells, M. B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 2011, 51, 2778-2786.
50. Wallace, A. C.; Laskowski, R. A.; Thornton, J. M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995, 8, 127-134.
51. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 1983, 4, 187-217.
52. Li, J.; Ehlers, T.; Sutter, J.; Varma-O'Brien, S.; Kirchmair, J. CAESAR: A new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration. J. Chem. Inf. Model. 2007, 47, 1923-1932.
53. Piao, L. Z.; Park, H. R.; Park, Y. K.; Lee, S. K.; Park, J. H.; Park, M. K. Mushroom tyrosinase inhibition activity of some chromones. Chem. Pharm. Bull. (Tokyo) 2002, 50, 309-311.
54. Takahashi, M.; Takara, K.; Toyozato, T.; Wada, K. A novel bioactive chalcone of Morus australis inhibits tyrosinase activity and melanin biosynthesis in B16 melanoma cells. J. Oleo Sci. 2012, 61, 585-592.